Royal Bank of Canada »

Bridgebio Pharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $507k 450k 1.13

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Bridgebio Pharma

Linden Advisors
Ing Investment Management
Context Capital Management
MacKay Shields
Lord, Abbett & Co
Wolverine Asset Management
Silverback Asset Management
Laurion Capital Management
Advent Capital Management
State Street Corporation
BlackRock
Wells Fargo & Company
FMR
OZ Management
Lazard Asset Management

View all funds holding Bridgebio Pharma